IL1B and thoracic aortic aneurysm: Inhibition of IL-1β through genetic and pharmacological strategies decreased formation and enlargement of thoracic aortic aneurysms, suggesting that IL-1β may be a potential target for thoracic aortic aneurysm treatment [41].